Future-proofing tuberculosis therapy: Saluzzo et al. propose a framework for concurrent development of TB drugs and resistance testing to help preserve the effectiveness of new treatments.
https://t.co/HR3R3cliBn
h/t Emory TRAC
🫁 Don’t miss today’s Clinic Year in Review – Part 3, featuring CF / Non-CF Bronchiectasis by Dr. Shelby Macrae.
📍 W320, Level III, OCCC West
🕘 Starting at 9:15 AM
ATS day. One of the beautiful things is seeing curious, dedicated people come together to contribute to the field. Proud of the work shared today. #bronchiectasis#ats2026@ATS_PITB@MayoPCCM
Happening now at W204B: Dr. Paula Bloski and Barbara Jones kicking off the session “Question Everything: Rethinking Conventional Approaches to CAP.” #ATS2026
Congratulations to our #ATS2026 PI-TB Awardees.
🌟 Dr. Ashley Losier (Early career award)
🌟 Dr. Sara Auld (Mid career award)
🌟 Dr. Charles Dela Cruz (Senior level award)
Starting at 2:15 PM today
🫁 Fungal Infections in Pulmonary and Critical Care.
📍A92
🫁 Acute Long COVID: Phenotypes, Mechanisms, and Long-Term consequences.
📍A108
🫁 The Science Behind the Magic: Re-engineering Host and Microbial Determinants of NTM Disease
📍A98
One week left for #ATS2026
Join us in Orlando for these exciting PITB sessions.
Take a look at what’s planned and explore the full schedule here:
https://t.co/7GeId16jL1
Adithya Cattamanchi (@acattamanchi), MD, a pulmonologist at UC Irvine and member of @ATS_PITB, and his colleagues recently developed a faster, more accessible test for TB that does not require phlegm to work.
Learn more about this new tool that could help patients and physicians around the world: https://t.co/ZpMwcXeTJ3